Anti-LCMV Glycoprotein GP2 Antibody from ProteoGenix; catalogue ARO-A22032; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-LCMV Glycoprotein GP2 Antibody: A Powerful Tool for Studying Lymphocytic Choriomeningitis Virus
Are you looking for a reliable and effective antibody to study the Lymphocytic Choriomeningitis Virus (LCMV)? Look no further than Anti-LCMV Glycoprotein GP2 Antibody.
This highly specific and sensitive antibody targets the glycoprotein GP2 of LCMV, a virus known for causing severe and sometimes fatal infections in humans. With its exceptional performance and versatility, Anti-LCMV Glycoprotein GP2 Antibody is a must-have tool for any research related to this virus.
Anti-LCMV Glycoprotein GP2 Antibody is a monoclonal antibody that binds to the GP2 glycoprotein of LCMV. This glycoprotein is essential for the virus to enter and infect host cells, making it a crucial target for studying LCMV.
This antibody is primarily used in immunofluorescence and immunohistochemistry techniques to detect and localize the presence of LCMV GP2 in infected cells and tissues. It can also be used in Western blotting and ELISA assays for quantitative analysis of GP2 expression.
Anti-LCMV Glycoprotein GP2 Antibody has been successfully used in various research studies, including:
– Understanding the molecular mechanisms of LCMV infection and pathogenesis
– Investigating the role of GP2 in viral entry and replication
– Developing diagnostic tools for LCMV infection
– Screening potential antiviral drugs against LCMV
With its high specificity and sensitivity, this antibody has been cited in numerous publications and has been a valuable tool for researchers studying LCMV.
In addition to its use in research, Anti-LCMV Glycoprotein GP2 Antibody has also shown promising results in animal studies as a potential therapeutic agent against LCMV.
In conclusion, Anti-LCMV Glycoprotein GP2 Antibody is a reliable and powerful tool for studying the Lymphocytic Choriomeningitis Virus. Its exceptional performance and versatility make it an essential component of any research related to this virus. So why wait? Get your hands on this antibody today and take your LCMV research to the next level.
Keywords: Anti-LCMV Glycoprotein GP2 Antibody, Lymphocytic Choriomeningitis Virus, glycoprotein GP2, immunofluorescence, immunohistochemistry, Western blotting, ELISA, viral infection, pathogenesis, antiviral drugs, therapeutic agent.
ProteoGenix catalogue number ARO-A22032. For research use only.
Target: GP2; Clonality: Polyclonal Antibody; Applications: ELISA, IHC, WB.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| GP2 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
